Home > Riviste > Minerva Urologica e Nefrologica > Fascicoli precedenti > Minerva Urologica e Nefrologica 2015 March;67(1) > Minerva Urologica e Nefrologica 2015 March;67(1):55-63

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Per citare questo articolo

 

REVIEW   

Minerva Urologica e Nefrologica 2015 March;67(1):55-63

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Robot-assisted surgical approach to bladder cancer: a decade of progress!

Al-Tartir T. 1, Raza S. 1, Alotaibi M. 2, Khan A. 1, Hara I. 3, Fujisawa M. 4, Guru K. 1

1 Urology Department, Roswell Park Cancer Institute, Buffalo, NY, USA; 2 Urology Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; 3 Department of Urology, Wakayama Medical University, Wakayama, Japan; 4 Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan


PDF


Robot-assisted radical cystectomy (RARC) has gained popularity and proven its efficacy, safety and reproducibility in the last decade. RARC has resulted in less blood loss, enhanced recovery, and shorter hospital stay. RARC has proven to have similar or better postoperative morbidity, mortality and equal oncologic, outcomes. Limiting factors to the acceptance of this surgical approach have included its steep learning curve and the lack of both long-term outcome data. This article systematically reviews the literature comparing the outcomes for RARC (comparisons with open radical cystectomy when performed at the same institution) with a focus on operative, complications, oncologic, functional and survival outcomes.

inizio pagina